Dawn Dawson

9.3k total citations
39 papers, 2.2k citations indexed

About

Dawn Dawson is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Dawn Dawson has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Dawn Dawson's work include Inflammatory mediators and NSAID effects (8 papers), Sexual function and dysfunction studies (6 papers) and Estrogen and related hormone effects (4 papers). Dawn Dawson is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Sexual function and dysfunction studies (6 papers) and Estrogen and related hormone effects (4 papers). Dawn Dawson collaborates with scholars based in United States, United Kingdom and South Korea. Dawn Dawson's co-authors include Joseph Willis, Sanford D. Markowitz, Kenneth D. Somers, Earl Lawrence, James K. V. Willson, Petra Platzer, James Lutterbaugh, Yongyou Zhang, Ronald M. Rerko and Theresa P. Pretlow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Dawn Dawson

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Dawson United States 21 921 562 388 357 345 39 2.2k
Kelly A. Chiles United States 7 1.9k 2.0× 498 0.9× 158 0.4× 124 0.3× 1.7k 5.0× 13 3.1k
Gerold Untergasser Austria 29 1.1k 1.2× 527 0.9× 201 0.5× 80 0.2× 370 1.1× 84 2.4k
Ken‐ichi Kozaki Japan 21 906 1.0× 312 0.6× 106 0.3× 61 0.2× 357 1.0× 34 1.5k
Min‐Wei Chen China 27 1.3k 1.4× 460 0.8× 118 0.3× 78 0.2× 411 1.2× 56 2.4k
Stefania Gelmini Italy 35 1.3k 1.4× 528 0.9× 87 0.2× 69 0.2× 716 2.1× 79 2.9k
Anthony J. Raffo United States 24 1.2k 1.3× 597 1.1× 70 0.2× 292 0.8× 351 1.0× 36 2.4k
Ken‐ichi Kozaki Japan 27 2.1k 2.3× 772 1.4× 332 0.9× 41 0.1× 1.3k 3.6× 38 2.9k
David R. Soto‐Pantoja United States 28 1.0k 1.1× 494 0.9× 258 0.7× 44 0.1× 289 0.8× 58 2.3k
Wojciech Jóźwicki Poland 23 525 0.6× 436 0.8× 343 0.9× 54 0.2× 179 0.5× 63 1.8k

Countries citing papers authored by Dawn Dawson

Since Specialization
Citations

This map shows the geographic impact of Dawn Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Dawson more than expected).

Fields of papers citing papers by Dawn Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Dawson. The network helps show where Dawn Dawson may publish in the future.

Co-authorship network of co-authors of Dawn Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Dawson. A scholar is included among the top collaborators of Dawn Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Dawson. Dawn Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garman, Katherine S., Gary W. Falk, Dawn Dawson, et al.. (2023). Genetic Defect in Submucosal Gland–Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk. Gastroenterology. 165(6). 1561–1564.e3. 1 indexed citations
2.
Joseph, Peronne, Salendra Singh, Adam Kresak, et al.. (2022). The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett’s Neoplasia. Gastroenterology. 163(5). 1228–1241. 12 indexed citations
3.
Das, Sudipto, Dawn Dawson, Andrew Dean, et al.. (2022). Mitigating inequalities at a large COVID-19 vaccination centre. Future Healthcare Journal. 9(3). 321–325.
4.
Hu, Bin, Kosuke Toda, Xiaoyu Wang, et al.. (2022). Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration. Journal of Medicinal Chemistry. 65(22). 15327–15343. 8 indexed citations
5.
Smith, Julianne, Dawn Dawson, Alvin Jogasuria, et al.. (2021). 15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration. JCI Insight. 6(6). 14 indexed citations
6.
Wang, Jiping, Nancy L. Cho, Ann G. Zauber, et al.. (2018). Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH. Cancer Epidemiology Biomarkers & Prevention. 27(7). 728–736. 14 indexed citations
7.
Fink, Stephen P., Dawn Dawson, Yongyou Zhang, et al.. (2014). Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. Carcinogenesis. 36(2). 291–298. 13 indexed citations
8.
Greer, Katarina B., et al.. (2013). Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis. Clinical and Translational Gastroenterology. 4(3). e31–e31. 12 indexed citations
9.
Kunos, Charles A., Tomas Radivoyevitch, Adam Kresak, et al.. (2012). Elevated Ribonucleotide Reductase Levels Associate With Suppressed Radio chemotherapy Response in Human Cervical Cancers. International Journal of Gynecological Cancer. 22(9). 1463–1469. 20 indexed citations
10.
Zhou, Dawang, Yongyou Zhang, Hongtan Wu, et al.. (2011). Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proceedings of the National Academy of Sciences. 108(49). E1312–20. 377 indexed citations
11.
Greer, Katarina B., Cheryl L. Thompson, Dawn Dawson, et al.. (2011). Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut. 61(5). 665–672. 57 indexed citations
12.
Zhao, Yiqing, Xiaodong Zhang, Kishore Guda, et al.. (2010). Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proceedings of the National Academy of Sciences. 107(6). 2592–2597. 63 indexed citations
13.
Yu, Jing, Pingfu Fu, John J. Pink, et al.. (2010). HPV Infection and EGFR Activation/Alteration in HIV-Infected East African Patients with Conjunctival Carcinoma. PLoS ONE. 5(5). e10477–e10477. 25 indexed citations
14.
Greer, Katarina B., et al.. (2010). M1093 Insulin/Insulin Like Growth Factor-1 Pathway in Barrett's Carcinogenesis. Gastroenterology. 138(5). S–330.
15.
Pagel, J.F., et al.. (2004). Obstructive Sleep Apnea in Sleepy Pediatric Psychiatry Clinic Patients: Polysomnographic and Clinical Correlates. Sleep And Breathing. 8(3). 125–131. 10 indexed citations
16.
Black, Jennifer D., et al.. (2003). ErbB family targeting.. PubMed. 4(12). 1451–4. 12 indexed citations
17.
Wilson, Keith E., David H. Mack, Dawn Dawson, et al.. (2003). PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.. PubMed. 63(7). 1568–75. 76 indexed citations
18.
Dawson, Dawn, et al.. (2002). Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene. 21(1). 78–86. 63 indexed citations
19.
Dawson, Dawn, et al.. (2000). Capillary recruitment in response to insulin is comparable to that seen during exercise. Circulation. 660–660. 1 indexed citations
20.
Dawson, Dawn, Earl Lawrence, Theresa P. Pretlow, et al.. (1998). Altered Expression of RET Proto-oncogene Product in Prostatic Intraepithelial Neoplasia and Prostate Cancer. JNCI Journal of the National Cancer Institute. 90(7). 519–523. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026